Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2a, Randomized, Blinded, Multicenter Study Investigating a Combination of AB-729 and VTP-300 to evaluate their safety and reactogenicity in Virologically-Suppressed Chronic Hepatitis B Participants

Next Previous
X
Search
Trial Profile

A Phase 2a, Randomized, Blinded, Multicenter Study Investigating a Combination of AB-729 and VTP-300 to evaluate their safety and reactogenicity in Virologically-Suppressed Chronic Hepatitis B Participants

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Imdusiran (Primary) ; Nivolumab (Primary) ; VTP 300 (Primary) ; Nucleoside reverse transcriptase inhibitors; Nucleotide reverse transcriptase inhibitors
  • Indications Hepatitis B
  • Focus Adverse reactions; Proof of concept
  • Acronyms IM-PROVE II
  • Sponsors Arbutus Biopharma

    • Most Recent Events

    • 15 Nov 2024 According to an Arbutus Biopharma media release, the company announced new data at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2024.
    • 15 Nov 2024 Results presented in an Arbutus Biopharma Media Release.
    • 15 Oct 2024 According to an Arbutus Biopharma media release, company will present poster of this trial at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2024, scheduled from November 15-19, 2024 in San Diego, CA.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top